antibiotics

Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Flag link:
Antibiotic maker Paratek, low on cash, agrees to a buyout
Antibiotic maker Paratek, low on cash, agrees to a buyout
BioPharma Dive
Paratek
antibiotics
M&A
Novo Nordisk Foundation
Flag link:
Pfizer says antibiotic is effective against tough-to-treat infections
Pfizer says antibiotic is effective against tough-to-treat infections
BioPharma Dive
Pfizer
antibiotics
clinical trials
drug-resistant infections
ATM-AVI
Flag link:
Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic
Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic
Medical Xpress
Merck
antibiotics
Recarbrio
FDA
BMJ
Flag link:
GSK's gepotidacin shows potential in urinary tract infections
GSK's gepotidacin shows potential in urinary tract infections
Marketscreener
GSK
antibiotics
UTIs
gepotidacin
Flag link:
What happened to all the antibiotics?
What happened to all the antibiotics?
Pharmaphorum
antibiotics
drug shortages
Flag link:
How antidepressants help bacteria resist antibiotics
How antidepressants help bacteria resist antibiotics
Nature
antibiotics
antibiotic resistance
antidepressants
Flag link:
Crushed by PhIII antibiotic flop, PolyPid says it got FDA support for a comeback — by focusing on subgroup
Crushed by PhIII antibiotic flop, PolyPid says it got FDA support for a comeback — by focusing on subgroup
Endpoints
PolyPid
clinical trials
FDA
antibiotics
Flag link:
Pfizer pledges to sell all of its products at cost to poor countries
Pfizer pledges to sell all of its products at cost to poor countries
Fierce Pharma
Pfizer
Paxlovid
antibiotics
Flag link:
Pharmacists, public health officials report nationwide amoxicillin shortage
Pharmacists, public health officials report nationwide amoxicillin shortage
Medical Marketing and Media
drug shortages
amoxicillin
antibiotics
Flag link:
GSK preps filing for novel antibiotic for urinary tract infections
GSK preps filing for novel antibiotic for urinary tract infections
Pharmaphorum
GSK
antibiotics
UTIs
gepotidacin
Flag link:
GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection
GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection
Fierce Biotech
GSK
Spero Therapeutics
antibiotics
tebipenem
Flag link:
CDC calls for increased research into vaccines, therapeutics and diagnostics to tackle antimicrobial resistance
CDC calls for increased research into vaccines, therapeutics and diagnostics to tackle antimicrobial resistance
Biopharma Reporter
CDC
antibiotics
antibiotic resistance
vaccines
antimicrobial resistance
R&D
Flag link:
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
Endpoints
antibiotics
antibiotic resistance
UTIs
Big Pharma
Flag link:
At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
Endpoints
AstraZeneca
IPOs
Enstasis
antibiotics
Flag link:
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
Flag link:
The antimicrobial pipeline is ‘dry’ and that’s a problem
The antimicrobial pipeline is ‘dry’ and that’s a problem
Pharmaforum
antibiotics
antibiotic resistance
drug discovery
drug development
Flag link:
New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns
New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns
Fierce Biotech
antibiotics
antibiotic resistance
AMR Action Fund
drug development
Flag link:
Pharma-backed antibiotic fund makes first investments
Pharma-backed antibiotic fund makes first investments
Pharmaforum
antibiotics
funding
AMR Action Fund
Venatorx Pharmaceuticals
Adaptive Phage Therapeutics
Flag link:
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Endpoints
Senate
legislation
China
antibiotics
Joe Biden
Flag link:

Pages